Edition:
India

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

0.40USD
1:09am IST
Change (% chg)

$-0.01 (-1.58%)
Prev Close
$0.40
Open
$0.40
Day's High
$0.40
Day's Low
$0.37
Volume
169,286
Avg. Vol
93,604
52-wk High
$23.70
52-wk Low
$0.36

Latest Key Developments (Source: Significant Developments)

Advaxis Inc Files For Offering Of Up To 11.8 Million Shares Of Common Stock And Warrants To Purchase Up To 8.9 Million Shares Of Common Stock
Monday, 22 Jul 2019 

July 22 (Reuters) - Advaxis Inc ::ADVAXIS INC FILES FOR OFFERING OF UP TO 11.8 MILLION SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE UP TO 8.9 MILLION SHARES OF COMMON STOCK.  Full Article

Advaxis Files Preliminary Prospectus Related To Offering Of Up To $17.25 Mln Shares
Wednesday, 3 Jul 2019 

July 2 (Reuters) - Advaxis Inc ::ADVAXIS INC FILES PRELIMINARY PROSPECTUS RELATED TO OFFERING OF UP TO $17.25 MILLION SHARES OF COMMON STOCK AND PRE-FUNDED WARRANTS - SEC FILING.  Full Article

Advaxis Posts Q2 Loss Per Share Of $1.59
Tuesday, 11 Jun 2019 

June 10 (Reuters) - Advaxis Inc ::ADVAXIS REPORTS SECOND QUARTER FISCAL 2019 FINANCIAL RESULTS AND PROVIDES PIPELINE UPDATE.Q2 LOSS PER SHARE $1.59.Q2 REVENUE $1.2 MILLION VERSUS $1.7 MILLION.AS OF APRIL 30, 2019, ADVAXIS HAD CASH AND CASH EQUIVALENTS OF $33.7 MILLION.  Full Article

Advaxis Announces Pricing Of Its Public Offering Of Common Stock
Wednesday, 3 Apr 2019 

April 3 (Reuters) - Advaxis Inc ::ADVAXIS ANNOUNCES PRICING OF ITS PUBLIC OFFERING OF COMMON STOCK.ADVAXIS ANNOUNCES PRICING OF ITS PUBLIC OFFERING OF COMMON STOCK.ADVAXIS INC - OFFERING AT A PRICE TO PUBLIC OF $4.00 PER SHARE.  Full Article

Advaxis Announces Proposed Public Offering Of Common Stock
Wednesday, 3 Apr 2019 

April 2 (Reuters) - Advaxis Inc ::ADVAXIS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.ADVAXIS - INTENDS TO USE NET PROCEEDS FROM OFFERING TO FUND ITS CONTINUED RESEARCH AND DEVELOPMENT INITIATIVES IN CONNECTION WITH ITS PRODUCT PIPELINE.  Full Article

Advaxis Reports Q1 EPS Of $0.18
Tuesday, 12 Mar 2019 

March 12 (Reuters) - Advaxis Inc ::ADVAXIS REPORTS FIRST QUARTER FISCAL 2019 FINANCIAL RESULTS AND PROVIDES CLINICAL PIPELINE UPDATE.Q1 EARNINGS PER SHARE $0.18.Q1 REVENUE $15.6 MILLION.  Full Article

Advaxis’ Phase 3 Aim2cerv Study Placed On Partial Clinical Hold By FDA Related To Cmc Requests
Thursday, 24 Jan 2019 

Advaxis Inc ::ADVAXIS’ PHASE 3 AIM2CERV STUDY PLACED ON PARTIAL CLINICAL HOLD BY FDA RELATED TO CMC REQUESTS.ADVAXIS INC - FDA DID NOT CITE ANY SAFETY ISSUES RELATED TO TRIAL AND ALL CURRENTLY ENROLLED PATIENTS WILL CONTINUE TO RECEIVE TREATMENT.ADVAXIS - NO NEW PATIENTS CAN ENROLL IN AIM2CERV UNTIL RESOLUTION OF FDA'S PARTIAL HOLD..ADVAXIS INC - HAVE ALREADY BEGUN EFFORTS TO ADDRESS FDA'S REQUESTS FOR INFORMATION.ADVAXIS - FDA'S RECENT COMMUNICATION STATES PARTIAL HOLD RELATED TO THEIR REQUESTS FOR ADDITIONAL INFORMATION PERTAINING TO CERTAIN AXAL CMC MATTERS.  Full Article

Advaxis - On Dec 10 Co Received Written Notice Of Termination From Amgen With Respect To License & Collaboration Agreement, Dated As Of Aug 1, 2016
Friday, 14 Dec 2018 

Dec 13 (Reuters) - Advaxis Inc ::ADVAXIS - ON DEC 10 CO RECEIVED WRITTEN NOTICE OF TERMINATION FROM AMGEN WITH RESPECT TO LICENSE & COLLABORATION AGREEMENT, DATED AS OF AUG 1, 2016.ADVAXIS INC - TERMINATION OF AGREEMENT IS EFFECTIVE AS OF FEBRUARY 8, 2019 - SEC FILING.ADVAXIS INC - AGREEMENT IS PERTAINING TO DEVELOPMENT AND COMMERCIALIZATION OF CO'S ADXS-NEO PROGRAM.ADVAXIS - CO'S ADXS-NEO STUDY IS CURRENTLY ENROLLING PATIENTS AND CO WILL EVALUATE WHETHER TO RE-PARTNER ADXS-NEO PROGRAM.ADVAXIS -UPON TERMINATION, LICENSE TO AMGEN TO TERMINATE & CO TO REGAIN WORLDWIDE RIGHTS FOR DEVELOPMENT & COMMERCIALIZATION OF ADXS-NEO PROGRAM.  Full Article

Advaxis Reports Fiscal 2018 Q3 Loss Per Share Of $0.27
Tuesday, 11 Sep 2018 

Sept 10 (Reuters) - Advaxis Inc ::ADVAXIS REPORTS FISCAL 2018 THIRD QUARTER BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.27.QTRLY REVENUE $1.2 MILLION VERSUS $3.1 MILLION.  Full Article

Advaxis Inc Files For Mixed Shelf Of Up To $250 Million
Friday, 24 Aug 2018 

Aug 23 (Reuters) - Advaxis Inc ::ADVAXIS INC FILES FOR MIXED SHELF OF UP TO $250 MILLION .  Full Article